Ai-Ping Cao
Overview
Explore the profile of Ai-Ping Cao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
66
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu J, Wang Y, Guo Y, Zheng R, Wang Y, Shen Y, et al.
Sci China Life Sci
. 2024 Sep;
68(2):416-430.
PMID: 39327392
As the elderly population expands, the pursuit of therapeutics to reduce morbidity and extend lifespan has become increasingly crucial. As an FDA-approved drug for chronic cholestatic liver diseases, tauroursodeoxycholic acid...
2.
Cao A, Wang Y, Shen Y, Liu Y, Liu J, Wang Y, et al.
Nutrients
. 2024 Aug;
16(16).
PMID: 39203802
Dendritic cells (DCs) are crucial in initiating and shaping both innate and adaptive immune responses. Clinical studies and experimental models have highlighted their significant involvement in various autoimmune diseases, positioning...
3.
Mao Y, Zeng M, Chen Y, Chen C, Fu Q, Cai X, et al.
Zhonghua Gan Zang Bing Za Zhi
. 2009 Dec;
17(11):847-51.
PMID: 19958646
Objective: To evaluate the efficacy and safety of Magnesium isoglycyrrhizinate in treatment of chronic liver diseases. Methods: It is a randomized, double-blind, multi-doses, active drug controlled, multi-center study. 480 proper...
4.
Mao Y, Zeng M, Li Y, Wang B, Shang J, Shi R, et al.
Zhonghua Gan Zang Bing Za Zhi
. 2009 Apr;
17(3):213-6.
PMID: 19335986
Objective: To evaluate the efficacy and safety of Capsule metadoxine in the treatment of alcoholic liver disease. Methods: A randomized double blind multicenter placebo-controlled clinical study was performed to evaluate...
5.
Lu L, Xu H, Wang Y, Xu X, Zeng M, Mao Y, et al.
Zhonghua Gan Zang Bing Za Zhi
. 2005 Oct;
13(10):786-8.
PMID: 16248957
No abstract available.
6.
Shen L, Li J, Zeng M, Fan S, Lu L, Bao H, et al.
Zhonghua Gan Zang Bing Za Zhi
. 2005 Feb;
13(2):117-20.
PMID: 15727698
Objective: It is important to use noninvasive methods to differentiate liver fibrosis and liver cirrhosis. A prospective study was conducted to evaluate the validity of ultrasonography (US) in evaluating the...
7.
Yang W, Liu R, Zeng M, Lu L, Chen X, Xu S, et al.
Zhonghua Gan Zang Bing Za Zhi
. 2004 Apr;
12(4):216-8.
PMID: 15099470
Objectives: To observe the role of PPARgamma during the activation process of hepatic stellate cells (HSC). Methods: By morphology and RT-PCR, we study the changes of expression of PPARgamma in...
8.
Lu L, Zeng M, Mao Y, Fang J, Song Y, Shen Z, et al.
World J Gastroenterol
. 2004 Apr;
10(8):1176-9.
PMID: 15069721
Aim: To study the inhibitory effect of oxymatrine on serum hepatitis B virus (HBV) DNA in HBV transgenic mice. Methods: HBV transgenic mice model was established by microinjection, and identified...
9.
Lu L, Zeng M, Mao Y, Li J, Qiu D, Fang J, et al.
World J Gastroenterol
. 2003 Dec;
9(12):2796-800.
PMID: 14669336
Aim: To explore the relationship between clinical findings of patients with chronic liver diseases and the pathologic grading and staging of liver tissues. Methods: The inflammatory activity and fibrosis of...
10.
Grading and staging of hepatic fibrosis, and its relationship with noninvasive diagnostic parameters
Lu L, Zeng M, Wan M, Li C, Mao Y, Li J, et al.
World J Gastroenterol
. 2003 Nov;
9(11):2574-8.
PMID: 14606100
Aim: To explore the grade and stage of pathology and the relationship between grading and staging of hepatic fibrosis and noninvasive diagnostic parameters. Methods: Inflammatory activity and fibrosis of consecutive...